New Jersey Administrative Code

(a) A qualified nuclear pharmacist shall meet the following requirements: 1. He or she is a pharmacist licensed to practice in the State of New Jersey; and 2. He or she meets minimal standards of training and experience in the handling of radioactive materials in accordance with …

(a) Each nuclear pharmacy must meet the following requirements for space: 1. The area for the storage, compounding and dispensing of radioactive drugs shall be completely separate from pharmacy areas for non-radioactive drugs; 2. Hot lab and storage area shall be a minimum of 120…

The holder of a nuclear pharmacy permit shall be responsible for the radioactive quality control of all drugs, including biologicals, dispensed or manufactured. Radioactive pharmaceutical quality controls include, but are not limited to, the carrying out and interpretation of dat…

The rules in this subchapter establish standards applicable to all pharmacists who seek to engage in collaborative practice with one or more physicians licensed by the Board of Medical Examiners. Only those activities that have been approved by the collaborating physician, consis…

(a) The following words and terms, as used in this subchapter, shall have the following meanings, unless the context clearly indicates otherwise: "Collaborative drug therapy management" means the cooperative management of a patient's drug, biological, and device-related health ca…

(a) In order to enter into an agreement to engage in the collaborative drug therapy management of a patient with a physician licensed in this State, a licensed pharmacist shall be pre-approved by the Board to engage in such activity. In order to obtain Board approval, a pharmacis…

(a) A pharmacist who engages in collaborative practice with one or more physicians shall provide the Board, upon request, with a signed copy of a collaborative practice agreement. The collaborative practice agreement shall be consistent with the example contained in N.J.A.C. 13:3…

(a) A collaborative practice protocol shall be developed for each different type of collaborative drug therapy management authorized by the physician under the collaborative practice agreement and shall identify those activities that may be performed by the collaborating pharmaci…

(a) Written informed consent shall be obtained from each individual patient participating in collaborative drug therapy management. Both the physician and the pharmacist shall retain a copy of the patient's written informed consent. The written informed consent shall:1. Contain t…

(a) Collaborative drug therapy management shall be between a single patient with whom the physician has a bona fide physician-patient relationship, the physician, and the patient's collaborative practice pharmacist(s) and shall address that patient's specific condition, disease o…

(a) Participation in, or withdrawal from, a collaborative practice agreement shall be voluntary on the part of a physician and a pharmacist. (b) Participation in, or withdrawal from, collaborative drug therapy management shall be voluntary on the part of the individual patient. N…

Any violation of the collaborative practice agreement or protocols on the part of the pharmacist may be deemed professional misconduct and may subject the pharmacist to discipline consistent with N.J.S.A. 45:1-21. Notes N.J. Admin. Code § 13:39-13.9

(a) A pharmacist shall be authorized to furnish self-administered hormonal contraceptives to a patient, in accordance with standardized procedures and protocols jointly developed and approved by the Board and the State Board of Medical Examiners as set forth at N.J.A.C. 13:39 App…

(a) In order for a pharmacist to be authorized to furnish self-administered hormonal contraceptives pursuant to the Protocol, the pharmacist shall: 1. Complete a training program compliant with N.J.A.C. 13:39-14.7; 2. Affirm, in writing, that the pharmacist has completed a traini…

(a) Pharmacists may furnish the following self-administered hormonal contraceptives pursuant to the Protocol: 1. Combined oral contraceptive pill; 2. Progestin-only oral contraceptive pill; 3. Patch; 4. Ring; and 5. Injectable hormonal contraceptive. (b) A pharmacist may not furn…

(a) When an individual requests a pharmacist to furnish a self-administered hormonal contraceptive, the pharmacist shall: 1. Have the patient complete the Health Screening Questionnaire prepared by the New Jersey Department of Health. Upon request and whenever possible, the Healt…

(a) If the pharmacist concludes, based on N.J.A.C. 13:39-14.4, that a self-administered hormonal contraceptive is indicated for the patient, the pharmacist may furnish one. The pharmacist shall:1. Ensure that the patient is appropriately instructed in the administration of the se…

(a) The pharmacist must keep the following records: 1. A written or electronic record for any patient screened and for any self-administered hormonal contraceptive that is furnished pursuant to the Protocol, including, without limitation, any completed Health Screening Questionna…

(a) In order to be authorized to furnish self-administered hormonal contraceptives pursuant to the Protocol, a pharmacist must successfully complete a training program recognized pursuant to (c) below that is at least four credits and trains the pharmacist to: 1. Screen patients …

(a) An applicant for initial licensure as a pharmacist in New Jersey shall satisfy the following requirements: 1. The applicant shall be at least 18 years of age and shall submit a completed application for initial licensure, which shall include a passport size photo of the appli…

Notes N.J. Admin. Code § 13:39-2.10 Recodified to N.J.A.C. 13:39-3.1 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Authorization to practice; display of license".

Notes N.J. Admin. Code § 13:39-2.11 Recodified to N.J.A.C. 13:39-3.2 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Replacement license".

Notes N.J. Admin. Code § 13:39-2.12 Recodified to N.J.A.C. 13:39-3.3 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Change of name".

Notes N.J. Admin. Code § 13:39-2.13 Recodified to N.J.A.C. 13:39-3.4 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Change of address of record; service of process".

Notes N.J. Admin. Code § 13:39-2.14 Recodified to N.J.A.C. 13:39-3.5 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Verification of licensure".

Notes N.J. Admin. Code § 13:39-2.15 Recodified to N.J.A.C. 13:39-3.6 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Reproduction of initial license prohibited".

Notes N.J. Admin. Code § 13:39-2.16 Recodified to N.J.A.C. 13:39-3.7 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Biennial license renewal; administrative suspension".

Notes N.J. Admin. Code § 13:39-2.17 Recodified to N.J.A.C. 13:39-3.8 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Reinstatement from administrative and disciplinary license suspensions".

Notes N.J. Admin. Code § 13:39-2.18 Recodified to N.J.A.C. 13:39-3.9 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Inactive licensure".

Notes N.J. Admin. Code § 13:39-2.19 Recodified to N.J.A.C. 13:39-3.10 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Steering prohibited".

(a) An applicant for initial licensure shall attain a passing score of not less than 75 on the North American Pharmacist Licensure Examination (NAPLEX). If an applicant fails the NAPLEX, he or she shall be required to repeat the examination. (b) An applicant for initial licensure…

Notes N.J. Admin. Code § 13:39-2.20 Recodified to N.J.A.C. 13:39-3.11 by R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(a), 41 N.J.R. 2969(b). Section was "Responsibilities of pharmacists".

(a) An applicant for initial licensure shall submit evidence of good moral character, which shall be an ongoing requirement for licensure. In determining whether the applicant shall be licensed in the State, the Board shall consider evidence, which demonstrates that the applicant…

An applicant for initial licensure as a pharmacist in the State shall submit his or her name, address and fingerprints for purposes of a criminal history background check to be conducted by the State of New Jersey pursuant to N.J.S.A. 45:1-28 et seq., P.L. 2002, c. 104, to determ…

The Board may refuse to issue a license to any applicant who has violated any law related to the practice of pharmacy or for any of the reasons set forth in N.J.S.A. 45:1-21 et seq. Notes N.J. Admin. Code § 13:39-2.5 New Rule, R.2009 d.247, effective 8/3/2009. See: 41 N.J.R. 371(…

(a) The following words and terms, when used in this section, shall have the following meanings, unless the context clearly indicates otherwise. "Extern preceptor" means an individual approved by an Accreditation Council for Pharmacy Education (ACPE)-approved school or college of…

(a) No person shall be employed as a pharmacy intern until he or she has been registered with the Board pursuant to this section and his or her preceptor has been approved by the Board pursuant to N.J.A.C. 13:39-2.6(c). (b) An applicant for registration as a pharmacy intern shall…

Notes N.J. Admin. Code § 13:39-2.8 Recodified from N.J.A.C. 13:39-2.9 and amended by R.1999 d.214, effective 7/19/1999. See: 31 N.J.R. 1151(a), 31 N.J.R. 1932(a). Substituted "being investigated for" for "involved in" following "examination is". Former N.J.A.C. 13:39-2.10, Writte…

Notes N.J. Admin. Code § 13:39-2.9 Amended by R.1994 d.351, effective 7/18/1994. See: 26 N.J.R. 1596(a), 26 N.J.R. 2905(a). Amended by R.1999 d.214, effective 7/19/1999. See: 31 N.J.R. 1151(a), 31 N.J.R. 1932(a). Rewrote the section. Recodified from N.J.A.C. 13:39-3.11 and amende…

(a) Reciprocal licensure of out-of-State pharmacists shall be limited to those pharmacists who have been duly licensed in mutually reciprocating states and who satisfy the requirements of this section. (b) A pharmacist currently licensed in a mutually reciprocating jurisdiction s…

(a) An applicant for licensure by reciprocity shall submit, as part of his or her licensure application, evidence of good moral character, which shall be an ongoing requirement for licensure. In determining whether the applicant shall be licensed in the State, the Board shall con…

The Board may refuse to issue a license to any applicant for licensure by reciprocity that has violated any law relating to the practice of pharmacy or for any of the reasons set forth in N.J.S.A. 45:1-21 et seq. Notes N.J. Admin. Code § 13:39-2A.3 New Rule, R.2009 d.247, effecti…

An applicant for licensure by reciprocity in the State shall submit his or her name, address and fingerprints for purposes of a criminal history background check to be conducted by the State of New Jersey pursuant to N.J.S.A. 45:1-28 et seq., P.L. 2002, c. 104, to determine wheth…

An applicant for reciprocal licensure shall pass the Multistate Pharmacy Jurisprudence Examination. A passing score of not less than 75 shall be attained. If an applicant fails the examination, he or she shall be required to repeat the examination. Notes N.J. Admin. Code § 13:39-…

(a) An applicant who has successfully satisfied all Board requirements for licensure and has been approved by the Board to be licensed shall receive an authorization signed by the Executive Director of the Board granting the applicant the right to practice pharmacy in the State o…

It shall be unlawful for a pharmacist to enter into an arrangement with a health care practitioner who is licensed to issue prescriptions, or any institution, facility, or entity that provides health care services, for the purpose of directing or diverting patients to or from a s…

(a) All pharmacists shall be responsible for compliance with all the rules, regulations and laws governing the practice of pharmacy. (b) Any pharmacist found to have violated the New Jersey Pharmacy Practice Act, N.J.S.A. 45:14-40 et seq., or the rules in this chapter, shall be s…